Nasdaq:US$13.40 (-0.37) | HKEX:HK$20.38 (-0.16) | AIM:£1.99 (+0.02)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture